Measuring unadulterated whole blood viscosity in patients with familial hypercholesterolemia on long-term LDL apheresis

被引：0
|
作者：
Moriarty, PM
Gibson, CA
Kensey, KR
Hogenauer, WN
机构：
[1] Univ Kansas, Sch Med, Kansas City, KS USA
[2] Rheol Inc, Exton, PA USA
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2002年 / 22卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P269
引用
收藏
页码：A47 / A47
页数：1
相关论文
共 50 条
  • [1] Atorvastatin improves blood rheology in patients with familial hypercholesterolemia (FH) on long-term LDL apheresis treatment
    Banyai, S
    Banyai, M
    Falger, J
    Jansen, M
    Alt, E
    Derfler, K
    Koppensteiner, R
    ATHEROSCLEROSIS, 2001, 159 (02) : 513 - 519
  • [2] Long-term effect of LDL-apheresis on familial hypercholesterolemia homozygotes
    Yamamoto, A
    Kawaguchi, A
    Harada-Shiba, M
    LIPOPROTEIN METABOLISM AND ATHEROGENESIS, 2000, : 19 - 25
  • [3] The long-term effect of LDL apheresis in a patient with heterozygous familial hypercholesterolemia
    Takeda, Y
    Saku, K
    Liu, K
    Ohta, T
    Zhang, B
    Jimi, S
    Arakawa, K
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 61 - 61
  • [4] Long-term effects of LDL apheresis in patients with severe hypercholesterolemia
    Sachais, BS
    Katz, J
    Ross, J
    Rader, DJ
    JOURNAL OF CLINICAL APHERESIS, 2005, 20 (04) : 252 - 255
  • [5] Long-Term Experience with LDL Apheresis in Patients with Familial Hypercholesterolemia (FH) in a Clinical Hospital Setting
    Shafi, H.
    Hayes, C.
    Edmunds, M. R.
    Pepkowitz, S.
    Klapper, E.
    TRANSFUSION, 2011, 51 : 85A - 86A
  • [6] Long-Term LDL-Apheresis Treatment and Dynamics of Circulating miRNAs in Patients with Severe Familial Hypercholesterolemia
    Dlouha, Dana
    Blaha, Milan
    Huckova, Pavlina
    Lanska, Vera
    Hubacek, Jaroslav Alois
    Blaha, Vladimir
    GENES, 2023, 14 (08)
  • [7] LONG-TERM LDL-APHERESIS TREATMENT AND DYNAMICS OF CIRCULATING MIRNAS IN PATIENTS WITH SEVERE FAMILIAL HYPERCHOLESTEROLEMIA
    Dlouha, D.
    Blaha, M.
    Huckova, P.
    Lanska, V.
    Hubacek, J.
    Blaha, V.
    ATHEROSCLEROSIS, 2023, 379
  • [8] Influence of aging on serum cholesterol levels in heterozygous familial hypercholesterolemia patients with long-term LDL apheresis therapy
    Miwa, K
    Toudou, Y
    Kawashiri, M
    Higashikata, T
    Inazu, A
    Koizumi, J
    Mabuchi, H
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 173 - 173
  • [9] Coronary calcification and regression of coronary atherosclerosis by long-term LDL-apheresis in patients with heterozygous familial hypercholesterolemia
    Ueda, K
    Higashikata, T
    Noto, M
    Kajinami, K
    Koizumi, J
    Mabuchi, H
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 303 - 303
  • [10] LONG-TERM LDL-APHERESIS (LDL-APH) IN THE TREATMENT OF CHILDREN WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (FH)
    ZWIENER, RJ
    UAUY, R
    BILHEIMER, DW
    PEDIATRIC RESEARCH, 1991, 29 (04) : A117 - A117
12345